AU2002245727A1 - Enhanced diagnostic potential of prostate-specific antigen expressing cells - Google Patents
Enhanced diagnostic potential of prostate-specific antigen expressing cellsInfo
- Publication number
- AU2002245727A1 AU2002245727A1 AU2002245727A AU2002245727A AU2002245727A1 AU 2002245727 A1 AU2002245727 A1 AU 2002245727A1 AU 2002245727 A AU2002245727 A AU 2002245727A AU 2002245727 A AU2002245727 A AU 2002245727A AU 2002245727 A1 AU2002245727 A1 AU 2002245727A1
- Authority
- AU
- Australia
- Prior art keywords
- prostate
- expressing cells
- specific antigen
- antigen expressing
- diagnostic potential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28137801P | 2001-04-05 | 2001-04-05 | |
US60/281,378 | 2001-04-05 | ||
PCT/US2002/009736 WO2002081656A2 (en) | 2001-04-05 | 2002-04-01 | Enhanced diagnostic potential of prostate-specific antigen expressing cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002245727A1 true AU2002245727A1 (en) | 2002-10-21 |
Family
ID=23077036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002245727A Abandoned AU2002245727A1 (en) | 2001-04-05 | 2002-04-01 | Enhanced diagnostic potential of prostate-specific antigen expressing cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002245727A1 (en) |
WO (1) | WO2002081656A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060121477A1 (en) * | 2002-09-12 | 2006-06-08 | Abraham Hochberg | Method for detection of micro-metastasis |
JP2006072656A (en) | 2004-09-01 | 2006-03-16 | Hitachi Software Eng Co Ltd | Primer design method for real time pcr |
EP2407555A1 (en) * | 2010-07-14 | 2012-01-18 | Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada | Methods and kits for the diagnosis of prostate cancer |
EP2407554A1 (en) * | 2010-07-14 | 2012-01-18 | Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron | Methods and kits for the diagnosis of prostate cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674682A (en) * | 1992-10-29 | 1997-10-07 | Thomas Jefferson University | Nucleic acid primers for detecting micrometastasis of prostate cancer |
WO1995028498A1 (en) * | 1994-04-15 | 1995-10-26 | The Trustees Of Columbia University In The City Of New York | Method for molecular staging of prostate cancer |
WO1996021042A2 (en) * | 1995-01-04 | 1996-07-11 | Trustees Of Boston University | Primers for the pcr amplification of metastatic sequences |
US5858673A (en) * | 1996-06-24 | 1999-01-12 | Charlotte-Mecklenburg Hospital Authority | Method for detecting prostate cells |
JP2002503814A (en) * | 1998-02-12 | 2002-02-05 | イムニベスト・コーポレイション | Methods and reagents for rapid and efficient isolation of circulating cancer cells |
-
2002
- 2002-04-01 WO PCT/US2002/009736 patent/WO2002081656A2/en not_active Application Discontinuation
- 2002-04-01 AU AU2002245727A patent/AU2002245727A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002081656A2 (en) | 2002-10-17 |
WO2002081656A3 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001291859A1 (en) | Use of copolycarbonates | |
AU2002320058A1 (en) | Magnetic-nanoparticle conjugates and methods of use | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002329951A1 (en) | Fixed-dried red blood cells | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU2002357079A1 (en) | Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase | |
AU2003239361A1 (en) | Customization of medical device | |
AU2001277653A1 (en) | Diagnosis of known genetic parameters within the MHC | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001258533A1 (en) | Construction of dies | |
AU2002245727A1 (en) | Enhanced diagnostic potential of prostate-specific antigen expressing cells | |
AUPR605601A0 (en) | Pipeite of sandwich construction | |
AU2003276844A1 (en) | Formulations of modified antibodies and methods of making the same | |
AU2002210438A1 (en) | Diagnosis of diseases which are associated with cd24 | |
AU2002250041A1 (en) | Putative human enzymes | |
AU2001266790A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2003219541A1 (en) | Antigen fragments for the diagnosis of toxoplasma gondii | |
AU2001294999A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002354255A1 (en) | Mtehod of analyzing gene expression | |
AU2002332606A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002224774A1 (en) | Human phospholipase a2-like enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |